Abstract
Cell surface expression of the human cytomegalovirus (HCMV) major envelope glycoprotein complex, gp55-116 (gB), was studied by using monoclonal antibodies and an HCMV gp55-116 (gB) recombinant vaccinia virus. HCMV-infected human fibroblasts and recombinant vaccinia virus-infected HeLa cells expresses three electrophoretically distinct proteins of Mr 170,000, 116,000, and 55,000 on their surface. These species have been previously identified within infected cells and purified virions. Two unique neutralizing epitopes were shown to be present on the cell surface gp55-116 (gB). Utilizing HeLa cells infected with the gp55-116 recombinant vaccinia virus as a specific immunosorbent, we have shown that approximately 40 to 70% of the total serum virus-neutralizing activity of a group of individuals with past HCMV infections was directed against this single envelope glycoprotein. The implications of this finding for vaccine development are discussed.
Full text
PDF![1079](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4871/249220/eaf67a7fd9a9/jvirol00058-0125.png)
![1080](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4871/249220/1342562f4626/jvirol00058-0126.png)
![1081](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4871/249220/61d380f6bddc/jvirol00058-0127.png)
![1082](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4871/249220/e1f2c300846b/jvirol00058-0128.png)
![1083](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4871/249220/f35c0587bef5/jvirol00058-0129.png)
![1084](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4871/249220/7242756dc6ec/jvirol00058-0130.png)
![1085](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4871/249220/a1593970dfff/jvirol00058-0131.png)
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alford C. A., Stagno S., Pass R. F. Natural history of perinatal cytomegaloviral infection. Ciba Found Symp. 1979;(77):125–147. doi: 10.1002/9780470720608.ch9. [DOI] [PubMed] [Google Scholar]
- Andreoni M., Faircloth M., Vugler L., Britt W. J. A rapid microneutralization assay for the measurement of neutralizing antibody reactive with human cytomegalovirus. J Virol Methods. 1989 Feb;23(2):157–167. doi: 10.1016/0166-0934(89)90129-8. [DOI] [PubMed] [Google Scholar]
- Betts R. F., Schmidt S. G. Cytolytic IgM antibody to cytomegalovirus in primary cytomegalovirus infection in humans. J Infect Dis. 1981 Jun;143(6):821–826. doi: 10.1093/infdis/143.6.821. [DOI] [PubMed] [Google Scholar]
- Britt W. J., Auger D. Identification of a 65 000 dalton virion envelope protein of human cytomegalovirus. Virus Res. 1985 Dec;4(1):31–36. doi: 10.1016/0168-1702(85)90018-8. [DOI] [PubMed] [Google Scholar]
- Britt W. J., Auger D. Synthesis and processing of the envelope gp55-116 complex of human cytomegalovirus. J Virol. 1986 Apr;58(1):185–191. doi: 10.1128/jvi.58.1.185-191.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Britt W. J., Chesebro B., Portis J. L. Identification of a unique erythroleukemia-associated retroviral gp70 expressed during early stages of normal erythroid differentiation. J Exp Med. 1984 Jun 1;159(6):1591–1603. doi: 10.1084/jem.159.6.1591. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Britt W. J. Neutralizing antibodies detect a disulfide-linked glycoprotein complex within the envelope of human cytomegalovirus. Virology. 1984 Jun;135(2):369–378. doi: 10.1016/0042-6822(84)90193-4. [DOI] [PubMed] [Google Scholar]
- Britt W. J., Vugler L. G. Processing of the gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus. J Virol. 1989 Jan;63(1):403–410. doi: 10.1128/jvi.63.1.403-410.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Britt W. J., Vugler L., Stephens E. B. Induction of complement-dependent and -independent neutralizing antibodies by recombinant-derived human cytomegalovirus gp55-116 (gB). J Virol. 1988 Sep;62(9):3309–3318. doi: 10.1128/jvi.62.9.3309-3318.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brunell P. A., Ross A., Miller L. H., Kuo B. Prevention of varicella by zoster immune globulin. N Engl J Med. 1969 May 29;280(22):1191–1194. doi: 10.1056/NEJM196905292802201. [DOI] [PubMed] [Google Scholar]
- Dix R. D., Pereira L., Baringer J. R. Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease. Infect Immun. 1981 Oct;34(1):192–199. doi: 10.1128/iai.34.1.192-199.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Famulari N. G., English K. J. Env gene products of AKR dual-tropic viruses: examination of peptide maps and cell surface expression. J Virol. 1981 Dec;40(3):971–976. doi: 10.1128/jvi.40.3.971-976.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gershon A. A., Steinberg S., Brunell P. A. Zoster immune globulin. A further assessment. N Engl J Med. 1974 Jan 31;290(5):243–245. doi: 10.1056/NEJM197401312900503. [DOI] [PubMed] [Google Scholar]
- Gretch D. R., Kari B., Rasmussen L., Gehrz R. C., Stinski M. F. Identification and characterization of three distinct families of glycoprotein complexes in the envelopes of human cytomegalovirus. J Virol. 1988 Mar;62(3):875–881. doi: 10.1128/jvi.62.3.875-881.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gönczöl E., Hudecz F., Ianacone J., Dietzschold B., Starr S., Plotkin S. A. Immune responses to isolated human cytomegalovirus envelope proteins. J Virol. 1986 May;58(2):661–664. doi: 10.1128/jvi.58.2.661-664.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hirsch M. S., Schooley R. T., Cosimi A. B., Russell P. S., Delmonico F. L., Tolkoff-Rubin N. E., Herrin J. T., Cantell K., Farrell M. L., Rota T. R. Effects of interferon-alpha on cytomegalovirus reactivation syndromes in renal-transplant recipients. N Engl J Med. 1983 Jun 23;308(25):1489–1493. doi: 10.1056/NEJM198306233082501. [DOI] [PubMed] [Google Scholar]
- Kari B., Lussenhop N., Goertz R., Wabuke-Bunoti M., Radeke R., Gehrz R. Characterization of monoclonal antibodies reactive to several biochemically distinct human cytomegalovirus glycoprotein complexes. J Virol. 1986 Nov;60(2):345–352. doi: 10.1128/jvi.60.2.345-352.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lussenhop N. O., Goertz R., Wabuke-Bunoti M., Gehrz R., Kari B. Epitope analysis of human cytomegalovirus glycoprotein complexes using murine monoclonal antibodies. Virology. 1988 Jun;164(2):362–372. doi: 10.1016/0042-6822(88)90549-1. [DOI] [PubMed] [Google Scholar]
- Meyers J. D., Flournoy N., Sanders J. E., McGuffin R. W., Newton B. A., Fisher L. D., Lum L. G., Appelbaum F. R., Doney K., Sullivan K. M. Prophylactic use of human leukocyte interferon after allogeneic marrow transplantation. Ann Intern Med. 1987 Dec;107(6):809–816. doi: 10.7326/0003-4819-107-6-809. [DOI] [PubMed] [Google Scholar]
- Meyers J. D., Flournoy N., Thomas E. D. Cytomegalovirus infection and specific cell-mediated immunity after marrow transplant. J Infect Dis. 1980 Dec;142(6):816–824. doi: 10.1093/infdis/142.6.816. [DOI] [PubMed] [Google Scholar]
- Meyers J. D., Flournoy N., Thomas E. D. Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years' experience. Rev Infect Dis. 1982 Nov-Dec;4(6):1119–1132. doi: 10.1093/clinids/4.6.1119. [DOI] [PubMed] [Google Scholar]
- Middeldorp J. M., Jongsma J., The T. H. Killing of human cytomegalovirus-infected fibroblasts by antiviral antibody and complement. J Infect Dis. 1986 Jan;153(1):48–55. doi: 10.1093/infdis/153.1.48. [DOI] [PubMed] [Google Scholar]
- Pass R. F., Long W. K., Whitley R. J., Soong S. J., Diethelm A. G., Reynolds D. W., Alford C. A., Jr Productive infection with cytomegalovirus and herpes simplex virus in renal transplant recipients: role of source of kidney. J Infect Dis. 1978 May;137(5):556–563. doi: 10.1093/infdis/137.5.556. [DOI] [PubMed] [Google Scholar]
- Quinnan G. V., Jr, Kirmani N., Rook A. H., Manischewitz J. F., Jackson L., Moreschi G., Santos G. W., Saral R., Burns W. H. Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. N Engl J Med. 1982 Jul 1;307(1):7–13. doi: 10.1056/NEJM198207013070102. [DOI] [PubMed] [Google Scholar]
- Quinnan G. V., Jr, Masur H., Rook A. H., Armstrong G., Frederick W. R., Epstein J., Manischewitz J. F., Macher A. M., Jackson L., Ames J. Herpesvirus infections in the acquired immune deficiency syndrome. JAMA. 1984 Jul 6;252(1):72–77. [PubMed] [Google Scholar]
- Rasmussen L. E., Nelson R. M., Kelsall D. C., Merigan T. C. Murine monoclonal antibody to a single protein neutralizes the infectivity of human cytomegalovirus. Proc Natl Acad Sci U S A. 1984 Feb;81(3):876–880. doi: 10.1073/pnas.81.3.876. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rubin R. H., Cosimi A. B., Tolkoff-Rubin N. E., Russell P. S., Hirsch M. S. Infectious disease syndromes attributable to cytomegalovirus and their significance among renal transplant recipients. Transplantation. 1977 Dec;24(6):458–464. doi: 10.1097/00007890-197712000-00010. [DOI] [PubMed] [Google Scholar]
- Stagno S., Pass R. F., Cloud G., Britt W. J., Henderson R. E., Walton P. D., Veren D. A., Page F., Alford C. A. Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. JAMA. 1986 Oct 10;256(14):1904–1908. [PubMed] [Google Scholar]
- Stagno S., Pass R. F., Dworsky M. E., Henderson R. E., Moore E. G., Walton P. D., Alford C. A. Congenital cytomegalovirus infection: The relative importance of primary and recurrent maternal infection. N Engl J Med. 1982 Apr 22;306(16):945–949. doi: 10.1056/NEJM198204223061601. [DOI] [PubMed] [Google Scholar]
- Stinski M. F. Human cytomegalovirus: glycoproteins associated with virions and dense bodies. J Virol. 1976 Aug;19(2):594–609. doi: 10.1128/jvi.19.2.594-609.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Utz U., Britt W., Vugler L., Mach M. Identification of a neutralizing epitope on glycoprotein gp58 of human cytomegalovirus. J Virol. 1989 May;63(5):1995–2001. doi: 10.1128/jvi.63.5.1995-2001.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Whelchel J. D., Pass R. F., Diethelm A. G., Whitley R. J., Alford C. A., Jr Effect of primary and recurrent cytomegalovirus infections upon graft and patient survival after renal transplantation. Transplantation. 1979 Dec;28(6):443–446. [PubMed] [Google Scholar]
- Winston D. J., Ho W. G., Lin C. H., Bartoni K., Budinger M. D., Gale R. P., Champlin R. E. Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation. Ann Intern Med. 1987 Jan;106(1):12–18. doi: 10.7326/0003-4819-106-1-12. [DOI] [PubMed] [Google Scholar]
- Yeager A. S., Grumet F. C., Hafleigh E. B., Arvin A. M., Bradley J. S., Prober C. G. Prevention of transfusion-acquired cytomegalovirus infections in newborn infants. J Pediatr. 1981 Feb;98(2):281–287. doi: 10.1016/s0022-3476(81)80662-2. [DOI] [PubMed] [Google Scholar]
- van der Voort L. H., de Leij L. F., The T. H. Characterization of membrane antigens on human cytomegalovirus-infected fibroblasts recognized by human antibodies. J Virol. 1989 Mar;63(3):1485–1488. doi: 10.1128/jvi.63.3.1485-1488.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]